Patient characteristics in the International Extranodal Lymphoma Study Group (IELSG) series of non-gastric mucosa-associated lymphoid tissue (MALT 0 lymphoma (n = 246).
| Clinical feature . | Percentage . |
|---|---|
| Median Age | 60 yrs |
| Median age range | 20-92 yrs |
| Male | 39% |
| PS (ECOG)>0 | 35% |
| Stage IV | 26% |
| Multiple MALT Sites | 13% |
| Lymph Node involvement | 16% |
| Bone marrow involvement | 13% |
| High serum lactate dehydrogenase (LDH) (n=213) | 23% |
| High β-2 microglobulin (n=125) | 36% |
| Hepatitis C infection (n=135) | 16% |
| B-symptoms | 7% |
| Clinical feature . | Percentage . |
|---|---|
| Median Age | 60 yrs |
| Median age range | 20-92 yrs |
| Male | 39% |
| PS (ECOG)>0 | 35% |
| Stage IV | 26% |
| Multiple MALT Sites | 13% |
| Lymph Node involvement | 16% |
| Bone marrow involvement | 13% |
| High serum lactate dehydrogenase (LDH) (n=213) | 23% |
| High β-2 microglobulin (n=125) | 36% |
| Hepatitis C infection (n=135) | 16% |
| B-symptoms | 7% |